| Kudva YC, Basu A, Jenkins GD, et al.
Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as Basal insulin. [Journal Article]
Endocr Pract 2007 May-Jun; 13(3):244-50.
Abstract | Full Citation | Find Related Articles | | Kassem HS, Zantout MS, Azar ST
Insulin therapy during Ramadan fast for Type 1 diabetes patients. [Journal Article]
J Endocrinol Invest 2005 Oct; 28(9):802-5.
Abstract | Full Citation | Find Related Articles | | Rhodes ET, Wolfsdorf JI, Cuthbertson DD, et al.
Effect of low-dose insulin treatment on body weight and physical development in children and adolescents at risk for type 1 diabetes. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Diabetes Care 2005 Aug; 28(8):1948-53.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Alemzadeh R, Berhe T, Wyatt DT
Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. [Clinical Trial, Journal Article]
Pediatrics 2005 May; 115(5):1320-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Odegard PS, Capoccia KL
Inhaled insulin: Exubera. [Journal Article, Review]
Ann Pharmacother 2005 May; 39(5):843-53.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kudva YC, Basu A, Jenkins GD, et al.
Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Diabetes Care 2005 Jan; 28(1):10-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Quattrin T, Bélanger A, Bohannon NJ, et al.
Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Diabetes Care 2004 Nov; 27(11):2622-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hollander PA, Blonde L, Rowe R, et al.
Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Diabetes Care 2004 Oct; 27(10):2356-62.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Alemzadeh R, Ellis JN, Holzum MK, et al.
Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. [Clinical Trial, Journal Article]
Pediatrics 2004 Jul; 114(1):e91-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Schatz D, Cuthbertson D, Atkinson M, et al.
Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression? [Clinical Trial, Controlled Clinical Trial, Journal Article]
Pediatr Diabetes 2004 Jun; 5(2):72-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
